
ThinkCyte provides a single-cell platform that enables faster, cheaper, label-free cell sorting and unbiased single-cell profiling to accelerate biological discovery and diagnostic development. Their core product, VisionSort, combines advanced hardware, machine learning and AI-driven morphological profiling with techniques such as fluorescence flow cytometry and ghost cytometry to identify and sort cells without labels. The company operates as a B2B SaaS/biotech provider and integrates with research workflows used by biomedical researchers, pharmaceutical companies, and cell therapy teams. VisionSort supports Cell Therapy R&D, Drug Discovery, and Disease Profiling by offering high-throughput morphological analysis and scalable sorting for translational research.

ThinkCyte provides a single-cell platform that enables faster, cheaper, label-free cell sorting and unbiased single-cell profiling to accelerate biological discovery and diagnostic development. Their core product, VisionSort, combines advanced hardware, machine learning and AI-driven morphological profiling with techniques such as fluorescence flow cytometry and ghost cytometry to identify and sort cells without labels. The company operates as a B2B SaaS/biotech provider and integrates with research workflows used by biomedical researchers, pharmaceutical companies, and cell therapy teams. VisionSort supports Cell Therapy R&D, Drug Discovery, and Disease Profiling by offering high-throughput morphological analysis and scalable sorting for translational research.